GlassScriptPhysician profile
Jon R Ball
NPI 1386033314
$430.66
in general payments reported to CMS, 2019-2025
12 companies · $166 in 2025
The $166 reported for 2025 was more than what 86% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
See the full distribution for Nurse Anesthetist, Certified Registered
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $49.38 · 2022: $51.49 · 2023: $88.33 · 2024: $75.53 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $329.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $118.71 | 2021-2023 | Mazor X System |
| Merck Sharp & Dohme LLC | $48.58 | 2021-2022 | |
| Masimo Corporation | $40.90 | 2022-2024 | Sedline |
| Edwards Lifesciences Corporation | $38.37 | 2024 | Hemosphere |
| Becton, Dickinson and Company | $38.36 | 2025 | Hemosphere |
| Lilly USA, LLC | $24.57 | 2025 | Omvoh |
| Inari Medical, INC. | $23.08 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abbott Laboratories | $20.99 | 2025 | Perclose Prostyle |
| Janssen Biotech, INC. | $20.70 | 2025 | Tremfya |
| Boston Scientific Corporation | $20.61 | 2025 | General - Angioplasty |
| Intercept Pharmaceuticals, INC. | $18.17 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $17.62 | 2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Ball listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.